Literature DB >> 9124815

Complex I function in familial and sporadic dystonia.

A H Schapira1, T Warner, M T Gash, M W Cleeter, C F Marinho, J M Cooper.   

Abstract

A significant proportion of patients with inborn errors of the mitochondrial respiratory chain exhibit movement disorders, particularly dystonia. Point mutations of mitochondrial DNA (mtDNA) are usually expressed systemically, and defects of platelet respiratory chain function have been described in patients with mtDNA mutations and Leber's hereditary optic neuropathy (LHON). Recent reports have documented families with dystonia in association with LHON and mtDNA complex I gene mutations. We have examined mitochondrial function in platelet mitochondria from patients with familial generalized dystonia (linked or not linked to 9q34) and sporadic focal dystonia. We confirm a previous report of a specific complex I defect in patients with sporadic focal dystonia but could not find any abnormality in patients with familial generalized dystonia, linked or not to 9q34. These results support the existence of a mitochondrial deficiency in sporadic focal dystonia and provide a biochemical dimension to the clinical and genetic distinction between focal and generalized familial dystonia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9124815     DOI: 10.1002/ana.410410421

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

2.  Complex I respiratory defect in LHON plus dystonia with no mitochondrial DNA mutation.

Authors:  K K Abu-Amero; T M Bosley; S Bohlega; D McLean
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia.

Authors:  David K Simon; Jennifer Friedman; Xandra O Breakefield; Joseph Jankovic; Mitchell F Brin; John Provias; Susan B Bressman; Michael E Charness; Daniel Tarsy; Donald R Johns; Mark A Tarnopolsky
Journal:  Neurogenetics       Date:  2003-05-17       Impact factor: 2.660

Review 4.  The genetics of dystonias.

Authors:  Mark S LeDoux
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

Review 5.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 6.  Experimental therapeutics for dystonia.

Authors:  H A Jinnah; Ellen J Hess
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

7.  Recent advances in the molecular pathogenesis of dystonia-plus syndromes and heredodegenerative dystonias.

Authors:  Catharina Casper; Eirini Kalliolia; Thomas T Warner
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

Review 8.  The mitochondrial death pathway: a promising therapeutic target in diseases.

Authors:  Sanjeev Gupta; George E N Kass; Eva Szegezdi; Bertrand Joseph
Journal:  J Cell Mol Med       Date:  2009-02-09       Impact factor: 5.310

9.  Differential expression of striatal proteins in a mouse model of DOPA-responsive dystonia reveals shared mechanisms among dystonic disorders.

Authors:  Maria A Briscione; Ashok R Dinasarapu; Pritha Bagchi; Yuping Donsante; Kaitlyn M Roman; Anthony M Downs; Xueliang Fan; Jessica Hoehner; H A Jinnah; Ellen J Hess
Journal:  Mol Genet Metab       Date:  2021-06-02       Impact factor: 4.204

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.